Wang Li, Lian Yan-Jie, Dong Jin-Sheng, Liu Ming-Kun, Liu Hong-Liang, Cao Zheng-Min, Wang Qing-Nan, Lyu Wen-Liang, Bai Yu-Ning
Department of Gastroenterology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Division of Cardiovascular, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
World J Gastroenterol. 2025 Mar 7;31(9):102053. doi: 10.3748/wjg.v31.i9.102053.
Chronic atrophic gastritis (CAG) is an important stage of precancerous lesions of gastric cancer. Effective treatment and regulation of CAG are essential to prevent its progression to malignancy. Traditional Chinese medicine (TCM) has shown multi-targeted efficacy in CAG treatment, with advantages in enhancing gastric mucosal barrier defense, improving microcirculation, modulating inflammatory and immune responses, and promoting lesion healing, . Clinical studies and meta-analyses indicate that TCM provides significant benefits, with specific Chinese herbal compounds and monomers demonstrating protective effects on the gastric mucosa through mechanisms including anti-inflammation, anti-oxidation, and regulation of cellular proliferation and apoptosis, . Finally, it is pointed out that the efficacy of TCM in the treatment of CAG requires standardized research and unified standards, and constantly clarifies and improves the evaluation criteria of each dimension of gastric mucosal barrier function.
慢性萎缩性胃炎(CAG)是胃癌癌前病变的重要阶段。有效治疗和调控CAG对于预防其进展为恶性肿瘤至关重要。中医在CAG治疗中已显示出多靶点疗效,在增强胃黏膜屏障防御、改善微循环、调节炎症和免疫反应以及促进病变愈合方面具有优势。临床研究和荟萃分析表明,中医具有显著益处,特定的中药化合物和单体通过抗炎、抗氧化以及调节细胞增殖和凋亡等机制对胃黏膜具有保护作用。最后指出,中医治疗CAG的疗效需要规范研究并统一标准,不断明确和完善胃黏膜屏障功能各维度的评估标准。